Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Angiogenesis, Pathologic

1-methyl-3-isobutylxanthine has been researched along with Angiogenesis, Pathologic in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lissitzky, JC1
Parriaux, D1
Ristorcelli, E1
Vérine, A1
Lombardo, D1
Verrando, P1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Angiogenesis, Pathologic

ArticleYear
Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
    Cancer research, 2009, Feb-01, Volume: 69, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; alpha-MSH; Cell Line, Tumor; Colforsin; Cyclic AMP; Guanine Nucleotide

2009